Storia in 10 fonti

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. | India News

Raccontata da

timesofindia.indiatimes.com

economictimes.indiatimes.com

hindustantimes.com

thehindubusinessline.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

hindustantimes.comStai leggendo2 g fa

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. | India News

originale

Timeline cronologica

mercoledì 22 luglio 2026·timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
mercoledì 22 luglio 2026·economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Trump ⁠has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Confronto fonti

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Pharma companies in a flux over Trump's 200% tariff move on generics

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump's generic drugs tariff threatens Indian pharma's top market

Trump threatens tariff on generic medicines: Should India be worried?

US to impose steep tariffs on generic medicine imports from Aug 2028

US to impose 100% tariffs on generic medicine imports from Aug 2028

Trump announces 100% tariffs on imported generic pharmaceutical drugs

Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan

Trump imposing 100pc tariff on generic drugs from August 2028

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Trump threatens tariff on generic medicines: Should India be worried?

Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals